HPV
Region Dalarna is now providing free HPV vaccine to men aged 18 to 26. The offer targets those born between 2000 and 2008, six years after boys were first recommended to vaccinate against the HPV virus.
Reported by AI
Researchers at Mass General Brigham have developed HPV-DeepSeek, a highly sensitive blood test that identifies HPV-associated head and neck cancers nearly a decade before symptoms appear. The test uses whole-genome sequencing to detect viral DNA fragments in the bloodstream. This advance could enable earlier treatments and improve patient outcomes.